Franchise opportunities compared
Galt Pharmaceuticals vs YESCO
Reviewed figures from each brand's Franchise Disclosure Document (FDD), side by side. Each figure carries its FDD year and page. This is not a ranking or recommendation, and the two FDDs may cover different years and location groups.
Initial investment · Item 7
Galt Pharmaceuticals
$122,350 – $348,700
2026 FDD · Item 7 · PDF p. 21YESCO
$65,000 – $432,200
2026 FDD · Item 7 · PDF p. 18Initial franchise fee · Item 5
Galt Pharmaceuticals
$100,000
2026 FDD · Item 5 · PDF p. 13YESCO
$50,000
2026 FDD · Item 5 · PDF p. 12Royalty · Item 6
Galt Pharmaceuticals
Not available
YESCO
6% or $1,000/mo min
2026 FDD · Item 6 · PDF p. 13Before you compare
- Both sets of figures come from 2026 FDDs.
- Item 19 figures cover the location groups each FDD names (Galt Pharmaceuticals: 4, YESCO: 1). Different groups are not directly comparable.
Financial commitment
Galt Pharmaceuticals
YESCOGalt Pharmaceuticals
YESCO
Galt Pharmaceuticals
YESCO
Galt Pharmaceuticals
YESCO
Galt Pharmaceuticals
YESCO
System scale & health
Galt Pharmaceuticals
YESCOGalt Pharmaceuticals
YESCO
Galt Pharmaceuticals
YESCO
Galt Pharmaceuticals
YESCO
Galt Pharmaceuticals
YESCO
Galt Pharmaceuticals
YESCO
Financial performance (Item 19), by location group
Galt Pharmaceuticals
YESCOItem 19 groups are shown separately and never combined. Revenue or sales figures are not profit. Net outlet change and turnover are Franopolis calculations from the disclosed counts; turnover is a count-based rate, not a measure of owner earnings.
Galt Pharmaceuticals vs YESCO: common questions
- Which costs less to open, Galt Pharmaceuticals or YESCO?
- Galt Pharmaceuticals: $122,350 – $348,700 (2026 FDD · Item 7 · PDF p. 21); YESCO: $65,000 – $432,200 (2026 FDD · Item 7 · PDF p. 18). These are each franchisor's Item 7 estimated initial investment. The low end of the disclosed estimate is lower for YESCO. Estimates are not quotes, and the FDD years may differ.
- Which has more locations, Galt Pharmaceuticals or YESCO?
- Galt Pharmaceuticals: 63 (2026 FDD · Item 20 · PDF p. 48); YESCO: 98 (2025 FDD · Item 20 · PDF p. 52). Total outlets from Item 20. Outlet counts do not indicate territory availability or franchisee results.
- Do Galt Pharmaceuticals and YESCO disclose financial performance (Item 19)?
- Galt Pharmaceuticals has reviewed Item 19 figures for 4 location groups; YESCO has reviewed Item 19 figures for 1 location group. Different location groups are not directly comparable, and revenue is not profit.
Answers restate the reviewed figures above. Not a ranking or recommendation.
Keep researching

Full Galt Pharmaceuticals report
Every reviewed fee, Item 19 group, outlet table and territory disclosure

Full YESCO report
Every reviewed fee, Item 19 group, outlet table and territory disclosure


